Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection

Journal of Infectious Diseases

Volumn 183, Issue 5, 2001, Pages 736-743

  Zaunders, John J ^a   Kaufmann, Gilbert R ^c   Cunningham, Philip H ^a   Smith, Don ^d   Grey, Pat ^d   Suzuki, Kazuo ^a   Carr, Andrew ^a,b   Goh, Li Ean ^e   Cooper, David A ^b,c  

^a Centre for Immunology   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; KI 67 ANTIGEN; LAMIVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TURNOVER TIME;

ADULT; ANTI-HIV AGENTS; CARBAMATES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DIDEOXYNUCLEOSIDES; EPSTEIN-BARR VIRUS INFECTIONS; FLOW CYTOMETRY; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN M; LAMIVUDINE; LONGITUDINAL STUDIES; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CCR5; SULFONAMIDES; TIME FACTORS; ZIDOVUDINE;

EID: 0035282814     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/318827     Document Type: Article

References (63)

1. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection
2. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection
3. Primary HIV infection: Host responses and intervention strategies
4. + T lymphocytes
5. Predictors of rapid progression to AIDS in HIV-1 seroconverters
6. + T-lymphocyte counts in the first year of HIV-1 infection
7. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: Partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia
8. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir
9. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
10. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
11. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
12. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
13. Biological properties of HIV isolates in primary HIV infection: Consequences for the subsequent course of infection
14. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
15. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection
16. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
17. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection
18. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus co-receptors: CXCR4, CCR3, and CCR5
19. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
20. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
21. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection
22. + T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1
23. IL-15 induces the expression of chemokines and their receptors in T lymphocytes
24. - T cells and monocytes from cord and adult blood
25. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
26. +) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
27. Requirement of MIP-1 alpha for an inflammatory response to viral infection
28. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67
29. + T lymphocytes in HIV-1 infection as measured by Ki-67 antigen
30. + T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis
31. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory
32. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
33. Factors influencing T-cell turnover in HIV-1-seropositive patients
34. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues
35. Relative significance of different pathways of immune reconstitution in HIV-1 infection as estimated by mathematical modeling
36. + T cells by accumulating recirculating lymphocytes in the lymphoid tissues
37. HIV induces homing of resting T lymphocytes to lymph nodes
38. Biological and virologic characteristics of primary HIV infection
39. + B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques
40. CD8 naive T cell counts decrease progressively in HIV-infected adults
41. + cells in late stages of HIV infection is related to increased risk of death: Evidence from a cohort of 347 HIV-infected individuals
42. HIV infection is active and progressive in lymphoid tissue during clinically latent stage of disease
43. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir
44. + T cell homeostasis and function in advanced HIV disease
45. Long-term cultures of HTLV-III-infected T cells: A model of cytopathology of T-cell depletion in AIDS
46. T-cell-mediated immunopathology versus direct cytolysis by virus: Implications for HIV and AIDS
47. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
48. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden
49. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus
50. Sexual transmission and propagation of SIV and HIV in resting and activated CD4(+) T cells
51. + T cells in vivo is determined by CCR5 coexpression and the state of cell activation in early SIV infection
52. Following the development of a CD4 T cell response in vivo: From activation to memory formation
53. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
54. + cell decline
55. + T cell responses associated with control of viremia
56. T-cell turnover in vivo and the role of cytokines
57. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection
58. Regulation of lymphocyte survival by the bcl-2 gene family
59. Mature T lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable antigenic environment
60. Lymphocyte activation during acute simian/human immunodeficiency virus SHIV(89.6PD) infection in macaques
61. Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production
62. Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry
63. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32